Exchange: OTC·Updated 12:57 PM EST

MEHCQ News

News
all
press releases
A U.S. bankruptcy judge ruled that California's appeal to block the deal was unlikely to succeed, rejecting claims that the sale violated state genetic privacy laws.
Stocktwits
The deal encompasses 23andMe’s core genome testing service, research operations, and Lemonaid Health, with TTAM set to relaunch the company as a nonprofit organization committed to upholding existing data privacy policies.
Stocktwits

Advertisement|Remove ads.